#USA #Wilmington #Medical Device #TMRW Vault #ReproTech

Reprotech's TMRW Vault® Receives CE Mark as Class IIa Medical Device

In a significant announcement made on July 6, 2026, Reprotech, based in Wilmington, Delaware, has successfully secured a CE mark for its innovative product, the TMRW Vault®. This recognition is in accordance with the European Medical Device Regulation (MDR), specifically under regulation (EU) 2017/745. This classification as a Class IIa medical device opens up pathways for the TMRW Vault® to be marketed not only within the European Union but also in other international markets that recognize CE certification.

The achievement marks a pivotal milestone not only for Reprotech as a leading enterprise in the reproductive health sector but also for the broader infertility treatment industry. The TMRW Vault® presents a groundbreaking solution that integrates advanced sample provenance controls, sophisticated monitoring systems, and scalable cryogenic storage capabilities. This innovative combination allows fertility clinics to mitigate risks, enhance sample traceability, and promote operational efficiency.

The TMRW Vault® and Its Functionalities

The TMRW Vault® is designed specifically for the safe storage of oocytes, embryos, and sperm in liquid nitrogen, ensuring optimal conditions for reproductive materials. One of the features of the TMRW Vault® is its compatibility with the TMRW Workstation, a state-of-the-art interface that facilitates the seamless movement of samples to and from the cryogenic storage unit while streamlining sample orders via the TMRW software protocol.

As fertility clinics manage an increasing volume of cryopreserved reproductive tissues, the necessity for secure, scalable, and verifiable storage solutions becomes paramount. Traditional manual inventory systems were prone to human error and inefficiencies, making it critical for clinics to adopt more advanced measures. The TMRW Vault® has been specifically engineered to modernize these processes by integrating a robust on-site cryogenic storage framework with TMRW's proprietary software platform, ivfOS.

This integrated system enhances sample identification through:

• - Digital sample management: Utilizing RFID-enabled CryoBeacons and ivfOS® software to allow for real-time identification and tracking of samples.
• - Automated storage access: Offering manual access to an automated storage tank to streamline the storage and retrieval process while maintaining full digital traceability for embryologists.
• - Advanced monitoring capabilities: Featuring TMRW Overwatch®, a system that conducts thousands of system checks each day under professional oversight, thus ensuring the integrity and reliability of stored samples.
• - Expanded storage capacity: The design allows a single Vault tank to accommodate up to ten traditional Dewar containers, efficiently using approximately one-third of the space.
• - Integration into a broader ecosystem: The TMRW Vault® is compatible with other TMRW services and external cryogenic storage solutions, facilitating a holistic approach to sample management.

The installation process of the TMRW Vault® is straightforward, enabling medical facilities to implement the system with minimal disruption, thereby enhancing overall operational capabilities.

The Future of Reproductive Health Management

This CE mark announcement closely follows the strategic merger between Reprotech and TMRW Life Sciences in April 2026, which pooled extensive experience in cryogenic storage and an existing network of sample banks across the United States alongside cutting-edge digital sample management technologies. Following the acquisition of IMT Matcher by Reprotech in June 2025, the newly formed organization now provides one of the most comprehensive ecosystems for clinics involved in fertility treatments, encompassing sample oversight, digital traceability, cryogenic storage both on-site and off-site, consent management, and billing administration.

Reprotech is recognized as a leading provider of products and services for securing, managing, and the long-term preservation of reproductive samples. Their offerings include seven specially designed biobanks, advanced cryogenic storage management technologies, and global solutions for digital sample provenance control. Together with their subsidiaries, TMRW, Matcher, and Cryologix, Reprotech collaborates with fertility centers to minimize risks, enhance traceability, optimize processes, and ensure sample safety at every stage of transportation.

With a commitment to innovation and regulatory compliance, Reprotech sets high standards for sample protection—ensuring safety today and sustainability for future generations. For more information, visit www.reprotech.com.

For media inquiries, please contact:
Sarah Roberts
Email: [email protected]